Pilot Therapeutics Holdings Inc.
PLTT
$0.0001
$0.000.00%
OTC PK
| 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | 06/30/2002 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 61.91% | -11.40% | -63.51% | -48.94% | 85.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.67% | -24.39% | -68.56% | -49.69% | 41.38% |
| Operating Income | -35.67% | 24.39% | 68.56% | 49.69% | -41.38% |
| Income Before Tax | -26.72% | 21.49% | 61.01% | 39.93% | -65.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.72% | 21.49% | 61.01% | 39.93% | -65.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.72% | 21.49% | 61.01% | 39.93% | -65.06% |
| EBIT | -35.67% | 24.39% | 68.56% | 49.69% | -41.38% |
| EBITDA | -36.58% | 24.23% | 68.83% | 49.83% | -41.39% |
| EPS Basic | -16.93% | 29.32% | 67.13% | 50.07% | -30.50% |
| Normalized Basic EPS | -16.90% | 29.33% | 67.53% | 46.74% | -51.05% |
| EPS Diluted | -16.93% | 29.32% | 67.13% | 50.07% | -30.50% |
| Normalized Diluted EPS | -16.90% | 29.33% | 67.53% | 46.74% | -51.05% |
| Average Basic Shares Outstanding | 8.38% | 11.10% | 18.66% | 12.73% | 9.35% |
| Average Diluted Shares Outstanding | 8.38% | 11.10% | 18.66% | 12.73% | 9.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |